MAXIMUM_CURIOSITY_RUTHLESS_CALIBRATION. Evidence confidence is a non-probabilistic quality/depth index and remains separate from edge/asymmetry. High edge with limited evidence remains visible for research instead of being averaged away.
| Asset | State | Evidence confidence | Edge/asymmetry | Screen state | Blind-spot angles |
|---|---|---|---|---|---|
| SANM | HIGH_EDGE_LIMITED_EVIDENCE | MODERATE (60% index) | 72% | DEEP_RESEARCH | question: growth_vs_valuation_tension; question: bottleneck_or_second_order_beneficiary |
| HTZ | EDGE_HYPOTHESIS_LIMITED_EVIDENCE | MODERATE (60% index) | 70% | SCREEN | evidence: distribution_dependencyTargeted evidence follow-upsFinancial basis reconciliationNO_LARGE_SUMMARY_DIFFERENCE_OBSERVED Primary revenue: 8,695,000,000 USD, period ending 2026-03-31. Tax-inclusive revenue alternative: 249,000,000 USD. The primary concepts and their periods are retained for audit. Publisher summary dates do not verify matching financial periods. Standardized free cash flow does not establish cash distributable to equity.
Formal thesis review draftEVIDENCE_FOLLOWUP_REQUIRED Reported evidence and scenario conditions need review. No approved thesis or capital allocation follows from this draft. Spending lines remain separate. A spending-definition discrepancy can be resolved only by the explicit matched-period bridge below. Reported charges have not been normalized away. Open questions
Final pre-purchase thesis breaker remains unselected. Review completion and capital eligibility remain false; zero decision weight. |
| OP | EDGE_HYPOTHESIS_LIMITED_EVIDENCE | MODERATE (72% index) | 67% | DEEP_RESEARCH | evidence: network_operational_trendTargeted evidence follow-upsBUYBACK_EXECUTION_REPORTED_CUSTODY_AND_NET_CAPTURE_UNVERIFIED Project reports are separate from verified holder economics; zero decision weight.
OP settlement and custody observationsSCOPED_RPC_TRANSFERS_OBSERVED_CAPTURE_UNVERIFIED Amounts and timing are observations. Revenue funding, wallet control, disposal purpose and net holder capture remain unverified. OP balance: 14389381.5197749536868392 at finalized block 157897191.
RPC transfers observed: 6; indexed records corroborated: 6. Complete wallet history has not been verified.
Formal thesis review draftEVIDENCE_FOLLOWUP_REQUIRED Reported evidence and scenario conditions need review. No approved thesis or capital allocation follows from this draft. Spending lines remain separate. A spending-definition discrepancy can be resolved only by the explicit matched-period bridge below. Reported charges have not been normalized away. Open questions
Final pre-purchase thesis breaker remains unselected. Review completion and capital eligibility remain false; zero decision weight. |
| RIF | EDGE_HYPOTHESIS_LIMITED_EVIDENCE | MODERATE (60% index) | 65% | DEEP_RESEARCH | question: network_activity_vs_token_valuation_tension; question: ecosystem_bottleneck_or_second_order_winner |
| XPR | EDGE_HYPOTHESIS_LIMITED_EVIDENCE | MODERATE (60% index) | 60% | DEEP_RESEARCH | question: network_activity_vs_token_valuation_tension; question: ecosystem_bottleneck_or_second_order_winner |
| ARB | STANDARD_RESEARCH | MODERATE (72% index) | 57% | DEEP_RESEARCH | evidence: network_operational_trendTargeted evidence follow-upsHISTORICAL_STAKING_PROPOSAL_DISTRIBUTION_NOT_ACTIVATED Project reports are separate from verified holder economics; zero decision weight.
Formal thesis review draftEVIDENCE_FOLLOWUP_REQUIRED Reported evidence and scenario conditions need review. No approved thesis or capital allocation follows from this draft. Spending lines remain separate. A spending-definition discrepancy can be resolved only by the explicit matched-period bridge below. Reported charges have not been normalized away. Open questions
Final pre-purchase thesis breaker remains unselected. Review completion and capital eligibility remain false; zero decision weight. |
This lane is reserved for candidates outside the ordinary DEEP_RESEARCH path. It selects the strongest eligible stock and crypto by relative edge, carries zero thesis weight, excludes severe-risk states, and records a 180-day outcome-ready cohort snapshot.
| Asset | State | Evidence confidence | Edge/asymmetry | Screen state | Blind-spot angles |
|---|---|---|---|---|---|
| HTZ | EDGE_HYPOTHESIS_LIMITED_EVIDENCE | MODERATE (60% index) | 70% | SCREEN | evidence: distribution_dependencyTargeted evidence follow-upsFinancial basis reconciliationNO_LARGE_SUMMARY_DIFFERENCE_OBSERVED Primary revenue: 8,695,000,000 USD, period ending 2026-03-31. Tax-inclusive revenue alternative: 249,000,000 USD. The primary concepts and their periods are retained for audit. Publisher summary dates do not verify matching financial periods. Standardized free cash flow does not establish cash distributable to equity.
Formal thesis review draftEVIDENCE_FOLLOWUP_REQUIRED Reported evidence and scenario conditions need review. No approved thesis or capital allocation follows from this draft. Spending lines remain separate. A spending-definition discrepancy can be resolved only by the explicit matched-period bridge below. Reported charges have not been normalized away. Open questions
Final pre-purchase thesis breaker remains unselected. Review completion and capital eligibility remain false; zero decision weight. |
| APT | STANDARD_RESEARCH | MODERATE (60% index) | 32% | SCREEN | evidence: network_operational_trendTargeted evidence follow-upsNO_EXACT_PROJECT_ROUTE Project reports are separate from verified holder economics; zero decision weight.
Formal thesis review draftEVIDENCE_FOLLOWUP_REQUIRED Reported evidence and scenario conditions need review. No approved thesis or capital allocation follows from this draft. Spending lines remain separate. A spending-definition discrepancy can be resolved only by the explicit matched-period bridge below. Reported charges have not been normalized away. Open questions
Final pre-purchase thesis breaker remains unselected. Review completion and capital eligibility remain false; zero decision weight. |
| State | Hypothesis | Priority |
|---|---|---|
| HYPOTHESIS | TransMedics Group, Inc. → materials / component dependency via materials / component dependency | 0.123 |
| HYPOTHESIS | TransMedics Group, Inc. → strategic partnership dependency via strategic partnership dependency | 0.070 |
Consensus is not claimed unless directly observed. Drawdown alone is not edge. Missing data is uncertainty, not negative evidence.